Skip to main content

Advertisement

SpringerLink
Log in

Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy

  • Letter to the Editor (by invitation)
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hata M, Tsujikawa A, Miyake M, Yamashiro K, Ooto S, Oishi A, Nakata I, Takahashi A, Yoshimura N (2015) Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab. Graefes Arch Clin Exp Ophthalmol 253:189–197

    Article  CAS  PubMed  Google Scholar 

  2. Tan CS, Ngo WK, Lim LW, Lim TH (2014) A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes. Br J Ophthalmol 98:1528–1533

    Article  PubMed  Google Scholar 

  3. Tamura H, Tsujikawa A, Otani A, Gotoh N, Sasahara M, Kameda T, Iwama D, Yodoi Y, Mandai M, Yoshimura N (2007) Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography. Br J Ophthalmol 91:1152–1159

    Article  PubMed  PubMed Central  Google Scholar 

  4. Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32:1453–1464

    Article  CAS  PubMed  Google Scholar 

  5. Hirami Y, Tsujikawa A, Otani A, Yodoi Y, Aikawa H, Mandai M, Yoshimura N (2007) Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy. Retina 27:335–341

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Nagahisa Yoshimura is a paid advisory board member for NIDEK. Additionally, he received lecture fees from Topcon and research funding from Canon.

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan

    Masayuki Hata, Akitaka Tsujikawa & Nagahisa Yoshimura

  2. Department of Ophthalmology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Miki-cho, Kagawa, 761-0793, Japan

    Masayuki Hata, Akitaka Tsujikawa & Nagahisa Yoshimura

Authors
  1. Masayuki Hata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akitaka Tsujikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nagahisa Yoshimura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akitaka Tsujikawa.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hata, M., Tsujikawa, A. & Yoshimura, N. Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 254, 1021–1022 (2016). https://doi.org/10.1007/s00417-015-3163-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-015-3163-3

Keywords

Search

Navigation